By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Wellgistics Health, Inc.

Wellgistics Health, Inc. (WGRX)

NASDAQ Currency in USD
$1.53
+$0.12
+8.51%
Last Update: 11 Sept 2025, 20:00
$107.09M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.62 - $7.04
52 Week Range

WGRX Stock Price Chart

Explore Wellgistics Health, Inc. interactive price chart. Choose custom timeframes to analyze WGRX price movements and trends.

WGRX Company Profile

Discover essential business fundamentals and corporate details for Wellgistics Health, Inc. (WGRX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Distribution

IPO Date

25 Feb 2025

Employees

31.00

CEO

Brian Leonard Norton

Description

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

WGRX Financial Timeline

Browse a chronological timeline of Wellgistics Health, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 9 Mar 2026

Upcoming earnings on 8 Dec 2025

Earnings released on 19 Aug 2025

EPS came in at -$0.11 , while revenue for the quarter reached $7.79M .

Earnings released on 12 May 2025

EPS came in at -$0.62 , while revenue for the quarter reached $10.86M .

WGRX Stock Performance

Access detailed WGRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run